J Med Cases
Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 4, Number 4, April 2013, pages 208-211


Recurrent Postpartum Thyroiditis in a Patient With Chronic Autoimmune Thyroiditis: A Case Report

Young Sik Choia, d, Bu Kyung Kima, Su Kyoung Kwona, Yo-Han Parka, Jeong Hoon Kimb, Eun Hee Kongc

aDepartment of Internal Medicine, Medicine, Kosin University College of Medicine, Busan, Korea
bDepartment of General Surgery, Medicine, Kosin University College of Medicine, Busan, Korea
cDepartment of Family Medicine, Kosin University College of Medicine, Busan, Korea
dCorresponding author: Young Sik Choi, Department of Internal Medicine, Kosin University College of Medicine, 34 Amnam-dong, Seo-gu, Busan, 602-702, Korea

Manuscript accepted for publication January 3, 2013
Short title: Recurrent Postpartum Thyroiditis
doi: https://doi.org/10.4021/jmc1060w

Abstract▴Top 

Postpartum thyroiditis is a destructive thyroiditis induced by an autoimmune mechanism that begins within the first few months after delivery. Postpartum thyroiditis can also occur after spontaneous abortion, here we report three documented episodes of recurrent postpartum thyroiditis, one of which developed after pregnancy loss. Our patient is a 33-year-old woman who complained of discomfort with palpitations two months after her first delivery. Laboratory examination of thyroid function tests (TFT) revealed transient hyperthyroidism followed by hypothyroidism and then recovery (a classic triphasic pattern). Two years later, the patient suffered a spontaneous abortion of her second pregnancy at 16 weeks gestation. Three months after the loss of this second pregnancy, TFT showed the classic triphasic pattern again. Two years following the spontaneous abortion, the patient gave birth to her second child, and three months after delivery, the patient complained of heat intolerance and irritability. Laboratory tests during this time showed an elevated FT4 and a low TSH. Tc-99m scintigraphy showed nonvisualization of both thyroid lobes, and 24-hour radioactive iodine uptake was 0.2%. This patient in this case presented with the classic triphasic pattern in all three episodes.

Keywords: Recurrent postpartum thyroiditis; Abortion; Chronic autoimmune thyroiditis

Introduction▴Top 

Postpartum thyroiditis is a destructive inflammation of the thyroid that is induced by an autoimmune mechanism within the first few months after delivery. After one episode of postpartum thyroiditis, there is a 70 percent chance of recurrence with subsequent pregnancies [1]. There has previously been a case that reported recurrent postpartum thyroiditis after each of three pregnancies [2]. The risk of spontaneous abortion in thyroid antibody-positive women is two- to four-fold greater than in antibody-negative women [3]. Postpartum thyroiditis can also occur after spontaneous or induced abortion [4], but a case of three documented episodes of postpartum thyroiditis, one of which developed after a spontaneous abortion, in a single patient has not yet been reported in the literature.

In this article, we report a patient with recurrent postpartum thyroiditis after each of three pregnancies, one of which developed after a spontaneous abortion.

Case Report▴Top 

A 33-year-old woman was referred to our clinic for treatment of chronic autoimmune thyroiditis. She was diagnosed with hypothyroidism with goiter at a local medical clinic and treated intermittently with levothyroxine. Physical examination of the neck revealed a diffusely enlarged and non-tender thyroid gland. Ultrasonography (US) was carried out using a real-time linear array 10 MHz transducer. The thyroid US demonstrated a diffusely enlarged thyroid gland with a 0.3 × 0.4 cm hypoechoic nodule in the right thyroid. The serial change in thyroid function tests (TFT) and the titer of autoantibodies over time are summarized in Table 1.

Table 1.
Click to view
Table 1. Change in Thyroid Function Tests and Autoantibody Titers
 

The patient gave birth to her first child. About one year before delivery, the results of a TFT were within normal limits with an increased titer of thyroid autoantibodies (Table 1). Two months after delivery, the patient complained of feeling unwell with palpitations. Laboratory examination showed that T3 was 331.6 pg/mL, (normal range: 65 - 181 pg/mL), thyroid-stimulating hormone (TSH) was 0.009 µIU/L (normal range: 0.35 - 5.50 µIU/L), free thyroxine (FT4) was 3.76 ng/dL (normal range: 0.89 - 1.76 ng/dL), antithyroglobulin was 39.0 U/mL (negative < 60 U/mL), antimicrosomal antibodies were 167.4 U/mL (negative < 60 U/mL), and thyrotropin-binding inhibitory immunoglobulin (TBII) was < 1 U/L (normal range: 0 - 10 U/L). Two months later, her TSH was 61.764 µIU/L and she was started on levothyroxine. Five month later, her TSH level returned to a normal range and levothyroxine was stopped.

The patient lost her second pregnancy to spontaneous abortion at 16 weeks of gestation. The patient had not been taking levothyroxine before conception or at the time of miscarriage. Three months after pregnancy loss, TFT revealed that T3 was 206.3 pg/mL, TSH was 0.273 µIU/L, and FT4 was 1.63 ng/dL. Two months later, her TSH level and titer of autoantibodies were markedly increased. She was restarted on levothyroxine and remained euthyroid (Table 1). Her second child was born. During this third pregnancy, she was taking levothyroxine and her thyroid function remained normal throughout. Three months after delivery, the patient complained of heat intolerance and irritability. Laboratory tests showed an elevated FT4 and a low TSH (Table 1). Tc-99m scintigraphy showed nonvisualization of both thyroid lobes, and 24-hour radioactive iodine uptake was 0.2% (Fig. 1), which suggested destructive thyroiditis. The patient was treated with a beta-blocker during this thyrotoxic period. During this thyrotoxic event, she developed postpartum thyroiditis with hyperthyroidism followed by hypothyroidism with an eventual return to normal thyroid function (Table 1).

Figure 1.
Click for large image
Figure 1. Tc- 99m scintigraphy shows nonvisualization of both thyroid lobes.
Discussion▴Top 

Postpartum thyroiditis causes lymphocytic inflammation of the thyroid within the first few months after delivery, and the prevalence of postpartum thyroiditis in iodine-sufficient areas ranges between 5-7% [5]. The disease is most common in women who have a high serum thyroid peroxidase antibody concentration during the first trimester of pregnancy or immediately after delivery [6] and in patients with a previous history of postpartum thyroiditis [1, 7]. The present case is of a woman living in Korea, which is an iodine-sufficient area [8]. The patient also had high titer of thyroid autoantibodies with a previous history of postpartum thyroiditis. Postpartum thyroiditis usually presents in one of three ways: transient hyperthyroidism alone, transient hypothyroidism alone, or transient hyperthyroidism followed by hypothyroidism and then recovery. Stagnaro-Green [9] reported that hypothyroidism occurs in 43 percent of patients before the recovery phase, hyperthyroidism in 32 percent, and hyperthyroidism followed by hypothyroidism in 25 percent. Only one-third of patients with postpartum thyroiditis develop the classic triphasic thyroid hormone pattern of transient hyperthyroidism followed by hypothyroidism and then recovery [6], which the present case exhibited in all three episodes. Hyperthyroidism usually occurs two to ten months after delivery, most commonly at three months, with recovery taking place over the next two to three months [10]. In the present patient, hyperthyroidism occurred two to three months after delivery. Hypothyroidism occurs between two and 12 months after delivery, most commonly at six months [10], and in the present case, hyperthyroidism occurred four to five months after delivery. Most patients have normal thyroid function at one year [10], and all three episodes in the present case recovered within one year.

Abortion is a common clinical problem, and several studies have revealed a strong correlation between presence of thyroid antibodies and spontaneous abortion [11-13]. Bagis et al [3] reported that 50% of thyroid autoantibody-positive women and 14.1% of thyroid autoantibody-negative patients had a history of spontaneous abortion. Othman et al [14] found that patients with postpartum thyroiditis and persistent hypothyroidism had a higher rate of spontaneous abortion than those patients who returned to a euthyroid state. In the present case, the patient was thyroid autoantibody-positive with postpartum thyroiditis. Therefore, both of these factors could have influenced the spontaneous abortion. There have been many other reports of postpartum thyroiditis that have developed after pregnancy loss [4, 15, 16]. Postpartum thyroiditis that develops after abortion may also be associated with presence of thyroid autoantibodies [4].

In summary, patients with postpartum thyroiditis with presence of thyroid autoantibodies have an increased risk of recurrence of thyroiditis and spontaneous abortion. Therefore, patients with postpartum thyroiditis should be carefully assessed during all pregnancies following the first instance of thyroiditis.


References▴Top 
  1. Lazarus JH, Ammari F, Oretti R, Parkes AB, Richards CJ, Harris B. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract. 1997;47(418):305-308.
    pubmed
  2. Gay JL, Nash ML. Recurrent postpartum painless thyroiditis. South Med J. 1980;73(12):1674-1675.
    doi
  3. Bagis T, Gokcel A, Saygili ES. Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid. 2001;11(11):1049-1053.
    doi pubmed
  4. Marqusee E, Hill JA, Mandel SJ. Thyroiditis after pregnancy loss. J Clin Endocrinol Metab. 1997;82(8):2455-2457.
    doi pubmed
  5. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev. 2001;22(5):605-630.
    doi pubmed
  6. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646-2655.
    doi pubmed
  7. Nicholson WK, Robinson KA, Smallridge RC, Ladenson PW, Powe NR. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid. 2006;16(6):573-582.
    doi pubmed
  8. Cho YW, Kim YS, Baick SH, Oh DY, Kim WJ, Kang MW, Kim KS. Analysis of Daily Intake and Urinary Excretion of Iodine normal Control and Patient with Thyroid Disease. J Kor Soc Endocrinol. 1994;9(4):307-317.
  9. Stagnaro-Green A. Clinical review 152: Postpartum thyroiditis. J Clin Endocrinol Metab. 2002;87(9):4042-4047.
    doi pubmed
  10. Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician. 2006;73(10):1769-1776.
    pubmed
  11. Rajatanavin R, Chailurkit LO, Tirarungsikul K, Chalayondeja W, Jittivanich U, Puapradit W. Postpartum thyroid dysfunction in Bangkok: a geographical variation in the prevalence. Acta Endocrinol (Copenh). 1990;122(2):283-287.
  12. Singh A, Dantas ZN, Stone SC, Asch RH. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril. 1995;63(2):277-281.
    pubmed
  13. Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol. 1997;90(3):364-369.
    doi
  14. Othman S, Phillips DI, Parkes AB, Richards CJ, Harris B, Fung H, Darke C, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf). 1990;32(5):559-564.
    doi
  15. Amino N, Miyai K, Kuro R, Tanizawa O, Azukizawa M, Takai S, Tanaki F, et al. Transient postpartum hypothyroidism: fourteen cases with autoimmune thyroiditis. Ann Intern Med. 1977;87(2):155-159.
    pubmed
  16. Stagnaro-Green A. Post-miscarriage thyroid dysfunction. Obstet Gynecol. 1992;80(3 Pt 2):490-492.
    pubmed


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Medical Cases is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org    elmer.editorial@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.